ABSTRACr The roles of antinuclear and DNA antibodies in the pathogenesis of cryptogenic fibrosing alveolitis were investigated in 53 patients. Twenty-two patients who had antinuclear antibodies detected in their serum had a significantly higher proportion of women, a higher prevalence of Raynaud phenomenon and digital vasculitis, and higher erythrocyte sedimentation rates, paralleled by raised serum globulin and IgG levels, than patients with no antinuclear antibodies detected. Serum antibodies to double-strand DNA (DS-DNA), assayed by a Farr binding technique, were significantly raised in 25% of patients with cryptogenic fibrosing alveolitis.
Cryptogenic fibrosing alveolitis denotes an interstitial pulmonary disease characterised by inflammatory cell infiltration of alveoli and distortion of the lung architecture with fibrous tissue. ' Since the disease is found in association with the autoimmune connective tissue diseases,2 hypergammaglobulinaemia,3 circulating non-organ-specific autoantibodies such as antinuclear antibodies and rheumatoid factors,4 and immune complexes in both serum and alveolar walls during active phases of the disease,"-an autoimmune pathogenesis has been proposed.
Immunoglobulins directed against nuclear antigens have been incriminated in the pathogenesis of systemic lupus erythematosus on the grounds that they form immune complexes which produce tissue damage by activating the complement pathway.8
Since antinuclear antibodies are also found in the sera of up to one-third of patients with cryptogenic fibrosing alveolitis,4 this study was designed to assess the prevalence and clinical associations of circulating antinuclear, double-strand DNA (DS-DNA), and single-strand DNA (SS-DNA) figure  1 . Thirteen of the combined groups of patients with cryptogenic fibrosing alveolitis had DS-DNA binding levels outside two standard deviations of the normal range, the mean value of 11-4 + 3-3% differing significantly from that of the normal control group (9-0 + 1-4%) (p < 0-001). No 
Discussion
This study identifies a subgroup of patients with cryptogenic fibrosing alveolitis who have circulating antinuclear antibodies, with a higher proportion of women, a greater prevalence of Raynaud phenomenon and digital vasculitis, higher serum globulin and IgG levels, and higher erythrocyte sedimentation rates than in patients who had no serum antinuclear antibodies detected. An association between digital vasculitis and antinuclear antibodies in patients with cryptogenic fibrosing alveolitis has been reported by Hodson et al, 13 who proposed an overlap syndrome with progressive systemic sclerosis. High titres of circulating antinuclear antibodies have been described in association with immunoglobulin and C3 deposits in the alveolar walls during the cellular phase of the disease, but a recent retrospective study failed to show that the presence of circulating antinuclear antibodies had any prognostic value in predicting steroid responsiveness or overall survival. 4 Over the last decade measurement of antibodies to double-strand DNA has proved of great value in the diagnosis and management of systemic lupus erythematosus. In our study we have found that a significant proportion of patients with cryptogenic fibrosing alveolitis also have significant increases in serum DS-DNA antibody levels, which overlap with the range found in systemic lupus erythematosus (fig 1) . In the latter antibodies to DNA form a major component of the circulating immune complexes, which cause tissue damage by activating the complement pathway and whose levels correlate with disease activity.8 In cryptogenic fibrosing alveolitis, however, the levels of DS-DNA antibody failed to correlate with any index of disease activity whether clinical, radiological, or physiological.
Raised levels of antibodies putatively directed against DS-DNA have also been reported in acute and chronic liver disease,'5 other autoallergic diseases,'6 and myasthenia gravis " and probably reflect antibody cross-reactivity to SS-DNA determinants of the DNA preparations used in the assays. 2 The serum of all the patients with cryptogenic fibrosing alveolitis had greatly enhanced binding capacity for SS-DNA, the values coming within the range observed for patients with systemic lupus erythematosus (fig 2) . Haslam et a16 found detectable serum precipitins to SS-DNA in 33% of patients with cryptogenic fibrosing alveolitis, and a high proportion of patients whose serum contained antinuclear antibodies had enhanced lymphocyte sensitivity to exogenous commercial DS-DNA.'8 In the present study SS-DNA antibodies were found in the serum of both the patients who were positive and those who were negative for antinuclear antibodies, but in the positive group a weak correlation existed between SS-DNA binding and the antibody titre.
The significance of increased DNA antibodies in cryptogenic fibrosing alveolitis is not apparent from this investigation. Haslam et We are grateful to the clinicians of the Brompton Hospital for allowing us to study their patients. The study was supported by a grant from the Heart, Chest, and Stroke Association.
